Precigen, Inc.

Precigen is a biotechnology company developing treatments based on gene and cell therapy, which means inserting genetic material into patients' cells to fight disease. The company's main platform is UltraCAR-T, which modifies a patient's immune cells to recognize and attack cancer cells. Precigen is also developing treatments for cancers, immune disorders, and viral infections using technology that delivers therapeutic genes into cells. The company's experimental treatments are currently in clinical trials testing their safety and effectiveness in patients.